According to filings with the U.S. Securities and Exchange Commission, AndHealth is raising up to $15,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About AndHealth
AndHealth works with the healthcare system to radically improve access and outcomes for the most challenging chronic health conditions, by providing whole-person specialty care and pharmacy in a partnership model that creates greater health equity for patients, lower costs for the healthcare system, and growth for existing providers. Community Health Centers (CHCs), Health Systems, providers, and plans work with AndHealth to provide high-quality and accessible whole-person specialty care that helps people get their lives back from chronic disease. Together with its partners, AndHealth enables a community based virtual and on-premises healthcare delivery system to address the nationwide specialty care access crisiswhile giving patients support for Social Drivers of Health (SDOH). Headquartered in Columbus, Ohio, AndHealth is led by former CoverMyMeds co-founder and CEO Matt Scantland and the team that helped grow healthcare technology company CoverMyMeds from inception to its $1.4 billion acquisition by McKesson in 2017 and is supported by key investors including the American Medical Associations innovation subsidiary, Francisco Partners, and the state of Ohios economic development organization.

To learn more about AndHealth, visit https://andhealth.com/
AndHealth Linkedin Page: https://www.linkedin.com/company/and-health/

Contact:
Matthew Scantland, President and Chief Executive Officer
614-321-9743
https://www.linkedin.com/in/mattscantland/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.